Trial intelligence / Profile preview

Metformin co-treatment in GnRH antagonist IVF for women with PCOS

ISRCTN21199799Phase 4Completed

Sponsor
Leeds Teaching Hospitals NHS Trust
Start
Jun 2009
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of metformin in polycystic ovary syndrome (PCOS), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Incidence of confirmed moderate and severe ovarian hyperstimulation syndrome requiring hospitalisation. Started Jun 2009; status: completed.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ISRCTN21199799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN21199799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call